PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.\', \'Research Center for Cancer Biology, China Medical University, Taichung 40402, Taiwan.\', \'Department of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan.\', \'Center for Molecular Medicine, China Medical University Hospital, Taichung 404332, Taiwan.\', \'Department of Hematology and Oncology, China Medical University Hospital, Taichung 404332, Taiwan.\', \'Department of Biotechnology, Asia University, Taichung 41354, Taiwan.\', \'Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 693810.3390/ijms22136938
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34203261
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34203261>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34203261>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all